PRTN3 and rheumatoid arthritis: These findings suggest that the enhanced and uncontrolled production of citrullinated antigens results in the development of an anti-citrullinated peptide antibody (ACPA) and the occurrence of joint inflammation in patients with the RA-susceptible PADI4 haplotype.